Alpha Genomix and Rx30 Partner to Provide Personalized Medication Therapy

Sep 30, 2016 5:04:39 PM | Industry News

Ocoee, FL, September 30, 2016 – Rx30 is announcing a first to market, actionable pharmacogenetic platform through Alpha Genomix Laboratories that will allow the pharmacist and physician to work collaboratively towards a true personalized medicine approach within their communities.  We have established an exclusive agreement with Alpha Genomix Laboratories, a leader in the field of precision medicine, to integrate an actionable, real-time approach to pharmacogenetics specifically for the independent pharmacist.